EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Psychosocial Functioning After Pediatric Bone Sarcoma: Generic and Survivor‐Specific Outcomes in Adolescent and Young Adult Patients

Hinke van der Hoek iD, Heleen Maurice-Stam, Laura R Beek, Jennifer van Dijk, Marjolein E M Langemeijer, Relinde W Slooff-Lentink, Alied M van der Aa-van Delden, Anne Westerweel, Marloes van Gorp, Hendrik W B Schreuder, Lianne M Haveman iD, W Peter Bekkering und 3 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Hinke van der Hoek und 14 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center For Pediatric Oncology, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Quality of Life, Bone Neoplasms, Cancer Survivors, Psychosocial Functioning. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric bone sarcoma patients and survivors may experience psychosocial challenges related to childhood cancer after their intensive, body‐altering treatment. This cross‐sectional study aimed to evaluate generic and survivor‐specific psychosocial outcomes in a national cohort of pediatric bone sarcoma patients and survivors, and to explore associations between these outcomes.

Methods

Patients treated for pediatric bone sarcoma, at least 2 years post‐diagnosis, completed age‐appropriate Pediatric Quality of Life Inventory (PedsQL) and PROMIS measures (generic outcomes). Patients ≥18 years additionally completed the impact of cancer–childhood survivor (IOC‐CS) (survivor‐specific outcomes). Generic psychosocial outcomes of patients were compared with age‐ and sex‐specific Dutch normative data using one‐sample t ‐tests. Linear regression analyses, adjusted for age and sex, examined associations between generic and survivor‐specific outcomes.

Results

In total, 139 patients participated (45% female). Mean age was 20.4 years (SD = 5.5) and mean time since end of treatment was 7.0 years (SD = 5.2). Patients scored significantly worse than normative values on cognitive functioning, pain interference, and health‐related quality of life. In other generic domains, such as depressive symptoms or anxiety, patients scored comparably to or better than normative values. Survivor‐specific outcomes were most positive in the socializing domain and most negative in the thinking and memory domain. Approximately 20% reported moderate‐to‐severe negative impact in at least one survivor‐specific domain.

Conclusion

Overall, pediatric bone sarcoma patients demonstrated psychosocial outcomes comparable to or more favorable than normative values. However, specific domains showed worse outcomes. In addition, a substantial subgroup experienced moderate‐to‐severe negative impacts of childhood cancer. This highlights the importance of monitoring psychosocial functioning and, where indicated, targeted interventions to address challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeBone NeoplasmsCancer SurvivorsPsychosocial FunctioningOsteosarcomaSarcomaHumansFemaleMaleAdolescentCross-Sectional StudiesChildYoung AdultAdultPrognosisFollow-Up Studies

Stichwörter der Autor:innen

childhood cancerpediatric oncologypsychosocial functioningpsycho‐oncologyquality of lifesupportive care

Autor:innen und Institutionen

  • Princess Máxima Center For Pediatric Oncology, Utrecht, the Netherlands.
  • Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
  • Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

ORCID-Profile: Hinke van der Hoek, Lianne M Haveman, Leonie G Tigelaar, Johannes H M Merks, Martha A Grootenhuis

Zitieren

APA

van der Hoek, H., Maurice-Stam, H., Beek, L. R., van Dijk, J., Langemeijer, M. E. M., Slooff-Lentink, R. W., van der Aa-van Delden, A. M., Westerweel, A., van Gorp, M., Schreuder, H. W. B., Haveman, L. M., Bekkering, W. P., Tigelaar, L. G., Merks, J. H. M., & Grootenhuis, M. A. (2026). Psychosocial Functioning After Pediatric Bone Sarcoma: Generic and Survivor‐Specific Outcomes in Adolescent and Young Adult Patients. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70487

Vancouver

van der Hoek H, Maurice-Stam H, Beek LR, van Dijk J, Langemeijer MEM, Slooff-Lentink RW, et al. Psychosocial Functioning After Pediatric Bone Sarcoma: Generic and Survivor‐Specific Outcomes in Adolescent and Young Adult Patients. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70487

BibTeX
@article{vanderHoek2026,
  author = {van der Hoek, Hinke and Maurice-Stam, Heleen and Beek, Laura R and van Dijk, Jennifer and Langemeijer, Marjolein E M and Slooff-Lentink, Relinde W and van der Aa-van Delden, Alied M and Westerweel, Anne and van Gorp, Marloes and Schreuder, Hendrik W B and Haveman, Lianne M and Bekkering, W Peter and Tigelaar, Leonie G and Merks, Johannes H M and Grootenhuis, Martha A},
  title = {Psychosocial Functioning After Pediatric Bone Sarcoma: Generic and Survivor‐Specific Outcomes in Adolescent and Young Adult Patients},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70487}
}
Kostenlos starten →